Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 11 pages · English
• Record December 2025 quarter global sales of US$6.1 million, up 38% PCP and 25% on the September 2025 quarter. • Last Twelve Months (LTM) global sales of ~US$21 million (A$32.2 million), up 24% year on year, ~3x the estimated industry growth rate(1), including six consecutive halves of sales growth in the United States, at a CAGR of ~40%. • Group cash outflow from operations for the quarter was
Story so far
Earlier from Nova Eye Medical
- Record Sales Result December 2025 Quarter
- Investor Webinar
- iTrack Advance Approved for Sale in China
- Investor Presentation 30 June 2025 Results
- Full year Financial Results
Later from Nova Eye Medical
- Half Yearly Report and Accounts
- EYE Delivers Sales Growth and Improves Bottom Line
- EYE lifts Sales Guidance
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical